PDEX Pro-Dex Inc. (co) Dashboard

Pro-Dex, Inc. engages in the design, development and manufacture of rotary drive surgical and dental instruments. The firm specializes in medical device and services, industrial and scientific, dental and component, repairs and other. Its products include finished medical devices, micro air-motors, dental products, plastic injection molding and torque wrenches. The company was founded on January 26, 1994 and is headquartered in Irvine, CA.

Company profile

Ticker

PDEX

Exchange

NASDAQ

Website

www.pro-dex.com/

CEO

Richard Van Kirk

Incorporated

California

Location

California

Fiscal year end

Jun 30

Sector

Manufacturing > Surgical and Medical Instrument Manufacturing

Industry (SIC)

Surgical & Medical Instruments & Apparatus

Boston Scientific • Baxter International • Becton, Dickinson And • 3M • Stryker • Teleflex • Resmed • Hill-Rom • Integra Lifesciences • Nuvasive ...

SEC CIK

0000788920

Corporate docs

Articles of Incorporation & Bylaws

IRS number

841261240

PDEX stock data

S&P 500

1M 1Y 2Y 5Y

News

Pro users get this 30m faster

64 Biggest Movers From Yesterday

25 Mar 21

Gainers HighPoint Resources Corporation (NYSE: HPR) shares jumped 118.8% to close at $10.83 on Wednesday.

101 Biggest Movers From Friday

8 Feb 21

Gainers Atlantic American Corporation. (NASDAQ: AAME) shares surged 117.6% to close at $5.20 on Friday after surging over 5% on Thursday.

Mid-Afternoon Market Update: Dow Surges 100 Points; Pro-Dex Shares Fall After Q2 Earnings

5 Feb 21

Toward the end of trading Friday, the Dow traded up 0.32% to 31,156 while the NASDAQ rose 0.58% to 13,857.49. The S&P also rose, gaining 0.45% to 3,889.17.

Mid-Day Market Update: Crude Oil Rises Over 1%; Document Security Systems Shares Slide

5 Feb 21

12 Health Care Stocks Moving In Friday's Intraday Session

5 Feb 21

Press releases

Pro users get this 30m faster

Pro-Dex, Inc. Announces Fiscal 2021 Second Quarter and Six-Month Results

4 Feb 21

IRVINE, CA / ACCESSWIRE / February 4, 2021 / PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2021 second quarter ended December 31, 2020. The Company also filed its Quarterly Report on Form

Calendar

4 Feb 21

17 Apr 21

30 Jun 21

Financial summary

Financial statements Chart PDEX financial data

Quarter (USD)	Dec 20	Sep 20	Jun 20	Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Jun 20	Jun 19	Jun 18	Jun 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated)	Burn method: Change in cash		Burn method: Operating income/loss		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	5.52M	5.52M	5.52M	5.52M	5.52M	5.52M
Cash burn (monthly)	(positive/no burn)	54.33K	(positive/no burn)	(positive/no burn)	(positive/no burn)	(positive/no burn)
Cash used (since last report)	n/a	193.65K	n/a	n/a	n/a	n/a
Cash remaining	n/a	5.33M	n/a	n/a	n/a	n/a
Runway (months of cash)	n/a	98.1	n/a	n/a	n/a	n/a

Beta Read what these cash burn values mean

Recent insider trades

PDEX insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
23 Feb 21	Katrina Marie Kramer Philp	Stock Option (Right-to-buy) Common Stock	Grant	Aquire A	No	No	27.5	4,000	110K	24,000
23 Feb 21	Cabillot Raymond E	Stock Option (Right-to-buy) Common Stock	Grant	Aquire A	No	No	27.5	4,000	110K	24,000
23 Feb 21	William James Farrell III	Stock Option (Right-to-buy) Common Stock	Grant	Aquire A	No	No	27.5	4,000	110K	24,000
23 Feb 21	Van Kirk Richard Lee Jr	Stock Option (Right-to-buy) Common Stock	Grant	Aquire A	No	No	27.5	18,000	495K	138,000
23 Feb 21	Swenson Nicholas John	Stock Option (Right-to-buy) Common Stock	Grant	Aquire A	No	No	27.5	4,000	110K	24,000

Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q4 2020

PDEX institutional ownership history Ownership history

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

29.1% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	25	24	+4.2%
Opened positions	3	6	-50.0%
Closed positions	2	4	-50.0%
Increased positions	7	6	+16.7%
Reduced positions	10	8	+25.0%

13F shares	Current	Prev Q	Change
Total value	37.11M	17.71M	+109.5%
Total shares	1.12M	619.29K	+81.2%
Total puts	0	0
Total calls	0	0
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Farnam Street Partners	360.85K	$13.53M	NEW
Vanguard	125.98K	$3.9M	-13.7%
FMR	124.45K	$3.85M	+1172.1%
Acadian Asset Management	95.81K	$2.97M	0.0%
BLK Blackrock	59.25K	$1.84M	-1.1%
Dimensional Fund Advisors	52.56K	$1.63M	+2.2%
Renaissance Technologies	50.66K	$1.57M	-0.4%
Globeflex Capital L P	35.37K	$1.1M	0.0%
EAM Investors	33.83K	$1.05M	-3.0%
LSV Asset Management	33.44K	$1.04M	-23.1%

Largest transactions	Shares	Bought/sold	Change
Farnam Street Partners	360.85K	+360.85K	NEW
FMR	124.45K	+114.67K	+1172.1%
Advisor	32.02K	+31.92K	+31919.0%
Vanguard	125.98K	-20.02K	-13.7%
Geode Capital Management	26.89K	+18.26K	+211.5%
LSV Asset Management	33.44K	-10.06K	-23.1%
O'shaughnessy Asset Management	12.96K	+9.01K	+228.1%
UBS UBS Group AG - Registered Shares	5.57K	+4.65K	+505.7%
NTRS Northern Trust	29.87K	-4.4K	-12.8%
Tower Research Capital	748	-1.88K	-71.5%

Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: accessory, Assignment, balloon, Commitment, Deed, direction, drawn, eliminated, Fixture, insurance, isolated, Land, monthly, Nasdaq, newly, ordinary, PDEX, prepayment, proportionately, purpose, refinancing, relocation, round, subsidiary, substantive, title, transfer, transition, wholly

Removed: banking, corporation, extended, October, overhead, recurring

From filing 10-Q 2021 Q2